Subscribe To
3 pharma stocks to buy for their promising progress
Identifying promising pharma stocks is no small feat in the dynamic and competitive realm of pharmaceutical...
July 31, 2023, 5:34 am
Fennec pharmaceuticals to report second quarter 2023 financial results on august 3, 2023
RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) -- Fennec pharmaceuticals Inc. (NASDAQ: FE...
July 31, 2023, 5:30 am
Annexon presents archer trial results at asrs 2023 highlighting potential of anx007 as a differentiated treatment for geographic atrophy
Additional analyses support consistent protection from vision loss Annexon to engage with regulatory agencies to determine optimal path forward for AN...
July 30, 2023, 4:00 pm
3 millionaire-maker biotech stocks to buy before the window closes
The pharmaceutical sector generates a huge $1.2 trillion of revenue globally, and the U.S. is by far th...
July 30, 2023, 3:00 pm
$pfe: buying weekly dips in pfizer before next big move
Pfizer, Inc. is an US American pharmaceutical and biotechnology company. Founded in 1849 and headquarte...
July 30, 2023, 12:52 am
Deep track capital, lp acquires new stake in terns pharmaceuticals inc
Deep Track Capital, LP (Trades, Portfolio), a prominent investment firm, recently made a significant move in the stock market by acquiring a new stake...
July 28, 2023, 6:02 pm
Biogen buys reata pharmaceuticals, expanding its lineup of rare disease drugs
Biogen said it was buying Reata pharmaceuticals for $7.3 billion, expanding its rare disease treatment ...
July 28, 2023, 4:40 pm
Lexicon pharmaceuticals to host second quarter 2023 financial results conference call and webcast on august 3, 2023
THE WOODLANDS, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Lexicon pharmaceuticals, Inc. (Nasdaq: LXRX) wi...
July 28, 2023, 4:01 pm
Eli lilly: there is no logic to this over optimism
Mounjaro may rake in $25B of annualized sales by 2026, exceeding ABBV's Humira. This naturally explains Mr. Market's optimism surrounding the LLY's st...
July 28, 2023, 4:00 pm
Why biogen agreed to acquire reata for $7.3 billion
Biogen agreed to acquire Reata pharmaceuticals for $7.3 billion, including debt, to expand its rare di...
July 28, 2023, 2:45 pm
Astrazeneca plc (azn) q2 2023 earnings call transcript
AstraZeneca PLC (NASDAQ:AZN ) Q2 2023 Earnings Conference Call July 28, 2023 6:45 AM ET Company Participants Andy Barnett - Head, Investor Relations P...
July 28, 2023, 1:34 pm
Reata pharmaceuticals stock opened 50% up on friday: what happened?
Shares of Reata pharmaceuticals Inc (NASDAQ: RETA) opened more than 50% up this morning after Biogen In...
July 28, 2023, 12:49 pm
Fate therapeutics to webcast conference call reporting second quarter 2023 financial results
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...
July 28, 2023, 12:00 pm
Humanigen stock removed from s&p total market index as firm faces bankruptcy
Humanigen Inc shares have plummeted more than 90% over the past month, and now trades at a little over a penny per share, after the clinical-stage bio...
July 28, 2023, 11:34 am
Why is reata pharmaceuticals (reta) stock up 53% today?
Reata pharmaceuticals (NASDAQ: RETA ) stock is soaring higher on Friday as investors react to an acquis...
July 28, 2023, 10:23 am
Biogen looks to bulk up rare disease portfolio with $7.3 billion acquisition
Biogen will buy Reata pharmaceuticals and its Friedreich's ataxia drug in a $7.3 billion deal....
July 28, 2023, 9:45 am
Why is tonix pharmaceuticals (tnxp) stock down 43% today?
Tonix pharmaceuticals (NASDAQ: TNXP ) stock is taking a beating on Friday after the company announced ...
July 28, 2023, 8:30 am
Why is siga technologies (siga) stock up 31% today?
SIGA Technologies (NASDAQ: SIGA ) stock is soaring higher on Friday after the pharmaceutical company s...
July 28, 2023, 8:05 am
Avicanna is pleased to announce the initial network of brands on the mymedi.ca platform
The MyMedi.ca medical cannabis care platform is preparing to launch August 1, 2023 The new cannabis care platform will offer a diverse portfolio of pr...
July 28, 2023, 7:30 am
Biogen to buy reata for $6.5 bln to bulk up rare disease portfolio
Biogen said it would buy biotech firm Reata pharmaceuticals for roughly $6.5 billion to expand its pres...
July 28, 2023, 7:21 am